Ancillary Studies

Ancillary studies proposals are defined as projects that involve the collection of new data or biological specimens directly from DFC participants or from DFC Investigators and/or the analyzation of existing DFC data or biological samples. For more information about ancillary projects, please

If you are a researcher and would like to collaborate with the DFC on an ancillary project, please click hereto download a copy of the DFC Ancillary Application.

RFA-DK-21-001 – Biomarkers for Diabetic Foot Ulcers through the Diabetic Foot Consortium (R61/R33 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement is to promote the development of prognostic, monitoring, and diagnostic biomarkers for diabetic foot ulcers that can be used in clinical trials and patient care. This initiative will support early analytical and clinical validation of biomarkers through a phased award to encourage innovative research. The initiative will leverage the resources of the Diabetic Foot Consortium to facilitate the access to well-characterized patients and high-quality human samples. The goal of this initiative is to deliver candidate biomarkers that are ready for definitive analytical and clinical validation studies through the Diabetic Foot Consortium.

If you are a researcher and would like apply for RFA-DK-21-001 please download and fill out theDFC Feasibility Form here.

For a link to the RFA-DK-21-001 information from the NIH, click here.

Helpful links